메뉴 건너뛰기




Volumn 87, Issue 11, 2012, Pages 1037-1039

Clostridium difficile: The emerging epidemic

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; COLESTYRAMINE; FIDAXOMICIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; METRONIDAZOLE; MONOCLONAL ANTIBODY; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; RIFAXIMIN; STOMACH SECRETION INHIBITOR; VANCOMYCIN; ANTIINFECTIVE AGENT;

EID: 84872253890     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2012.09.004     Document Type: Editorial
Times cited : (3)

References (15)
  • 1
    • 84872236149 scopus 로고    scopus 로고
    • Clostridium difficile infection: New insights into management
    • Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012;87(11):1106-1117.
    • (2012) Mayo Clin Proc. , vol.87 , Issue.11 , pp. 1106-1117
    • Khanna, S.1    Pardi, D.S.2
  • 3
    • 33750689923 scopus 로고    scopus 로고
    • Proton pump inhibitors and hospitalization for Clostridium difficile- associated disease: A population-based study
    • Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN. Proton pump inhibitors and hospitalization for Clostridium difficile- associated disease: a population-based study. Clin Infect Dis. 2006;43(10):1272-1276.
    • (2006) Clin Infect Dis. , vol.43 , Issue.10 , pp. 1272-1276
    • Lowe, D.O.1    Mamdani, M.M.2    Kopp, A.3    Low, D.E.4    Juurlink, D.N.5
  • 4
    • 77952196958 scopus 로고    scopus 로고
    • Proton pump inhibitors and risk for recurrent Clostridium difficile infection
    • Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010;170(9):772-778.
    • (2010) Arch Intern Med. , vol.170 , Issue.9 , pp. 772-778
    • Linsky, A.1    Gupta, K.2    Lawler, E.V.3    Fonda, J.R.4    Hermos, J.A.5
  • 5
    • 34547814762 scopus 로고    scopus 로고
    • Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: Analysis using pharmacovigilance tools
    • Hauben M, Horn S, Reich L, Younus M. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools. Int J Infect Dis. 2007;11(5):417-422.
    • (2007) Int J Infect Dis. , vol.11 , Issue.5 , pp. 417-422
    • Hauben, M.1    Horn, S.2    Reich, L.3    Younus, M.4
  • 6
    • 50649112615 scopus 로고    scopus 로고
    • Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients
    • Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol. 2008;103(9):2308-2313.
    • (2008) Am J Gastroenterol. , vol.103 , Issue.9 , pp. 2308-2313
    • Aseeri, M.1    Schroeder, T.2    Kramer, J.3    Zackula, R.4
  • 7
    • 84863496242 scopus 로고    scopus 로고
    • Gastric acid suppression and outcomes in Clostridium difficile infection: A population-based study
    • Khanna S, Aronson SL, Kammer PP, Baddour LM, Pardi DS. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study. Mayo Clin Proc. 2012;87(7):636-642.
    • (2012) Mayo Clin Proc. , vol.87 , Issue.7 , pp. 636-642
    • Khanna, S.1    Aronson, S.L.2    Kammer, P.P.3    Baddour, L.M.4    Pardi, D.S.5
  • 8
    • 56149107841 scopus 로고    scopus 로고
    • Diagnosis of Clostridium difficile infection by toxin detection kits: A systematic review
    • Planche T, Aghaizu A, Holliman R, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis. 2008;8(12):777-784.
    • (2008) Lancet Infect Dis. , vol.8 , Issue.12 , pp. 777-784
    • Planche, T.1    Aghaizu, A.2    Holliman, R.3
  • 9
    • 80051935450 scopus 로고    scopus 로고
    • Tests for the diagnosis of Clostridium difficile infection: The next generation
    • Carroll KC. Tests for the diagnosis of Clostridium difficile infection: the next generation. Anaerobe. 2011;17(4):170-174.
    • (2011) Anaerobe. , vol.17 , Issue.4 , pp. 170-174
    • Carroll, K.C.1
  • 10
    • 80052444456 scopus 로고    scopus 로고
    • Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: A meta-analysis
    • Deshpande A, Pasupuleti V, Rolston DD, et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis. 2011;53(7):e81-e90.
    • (2011) Clin Infect Dis. , vol.53 , Issue.7
    • Deshpande, A.1    Pasupuleti, V.2    Rolston, D.D.3
  • 11
    • 84863500695 scopus 로고    scopus 로고
    • Molecular techniques for diagnosis of Clostridium difficile infection: Systematic review and meta-analysis
    • O'Horo JC, Jones A, Sternke M, Harper C, Safdar N. Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis. Mayo Clin Proc. 2012;87(7):643-651.
    • (2012) Mayo Clin Proc. , vol.87 , Issue.7 , pp. 643-651
    • O'Horo, J.C.1    Jones, A.2    Sternke, M.3    Harper, C.4    Safdar, N.5
  • 12
    • 0031916601 scopus 로고    scopus 로고
    • Risk factors for early recurrent Clostridium difficile-associated diarrhea
    • Do AN, Fridkin SK, Yechouron A, et al. Risk factors for early recurrent Clostridium difficile-associated diarrhea. Clin Infect Dis. 1998;26(4):954-959.
    • (1998) Clin Infect Dis. , vol.26 , Issue.4 , pp. 954-959
    • Do, A.N.1    Fridkin, S.K.2    Yechouron, A.3
  • 13
    • 23944507069 scopus 로고    scopus 로고
    • Treatment of Clostridium difficile-associated disease: Old therapies and new strategies
    • Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis. 2005;5(9):549-557.
    • (2005) Lancet Infect Dis. , vol.5 , Issue.9 , pp. 549-557
    • Aslam, S.1    Hamill, R.J.2    Musher, D.M.3
  • 14
    • 79551527297 scopus 로고    scopus 로고
    • Fidaxomicin versus vancomycin for Clostridium difficile infection
    • Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422-431.
    • (2011) N Engl J Med. , vol.364 , Issue.5 , pp. 422-431
    • Louie, T.J.1    Miller, M.A.2    Mullane, K.M.3
  • 15
    • 74849098405 scopus 로고    scopus 로고
    • Treatment with monoclonal antibodies against Clostridium difficile toxins
    • Lowy I, Molrine DC, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362(3):197-205.
    • (2010) N Engl J Med. , vol.362 , Issue.3 , pp. 197-205
    • Lowy, I.1    Molrine, D.C.2    Leav, B.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.